P.A.W. Capital’s Apyx Medical APYX Stock Holding History

P.A.W. Capital’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-100,000	Closed	-$677K	–	62
2019 Q3	$677K	Sell	100,000 -20,000	-17%	-$142K	0.84%	38
2019 Q2	$806K	Buy	+120,000	New	+$652K	0.87%	29

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

P.A.W. Capital's APYX Position: Q4 2019 in Review

P.A.W. Capital sold out of Apyx Medical (APYX) in Q4 2019, closing a stake of 100,000 shares — an estimated $677K sold.

P.A.W. Capital first reported a position in APYX in Q2 2019 and held it in 2 quarters. The position peaked at $806K in Q2 2019. 69 funds tracked by Wall St. Rank hold APYX as of Q4 2019.

P.A.W. Capital reported no remaining Apyx Medical position as of Q4 2019 after selling out during the quarter.
P.A.W. Capital sold 100,000 Apyx Medical shares in Q4 2019, an estimated $677K.
P.A.W. Capital first reported a position in Apyx Medical in Q2 2019 and held it in 2 quarters.
P.A.W. Capital's Apyx Medical position peaked at $806K in Q2 2019.
69 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2019.

Based on P.A.W. Capital's 13F filing for Q4 2019, filed 28 Jan 2020.